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Introduction: The present study was carried out to explore the effectiveness of light therapy to reduce depression among hospitalized Depressive 
patient.  
Methods: Single subject [N=1] experimental design was utilized. Hamilton Rating Scale for Depression was administered to ascertain the level of 
depression. Light therapy was administered for a period of 7 consecutive days. The level of depression was assessed before and after the 
administration of light therapy.  
Results: The data was analyzed with the appropriate statistical technique. The result revealed that there was significant decrease in the level of 
depression after light therapy.  
Conclusions: This finding indicates that the light therapy has influenced in reducing the level of depression. Hence, light therapy can be adopted as 
an effective mechanism to treat depression. 
 




The present investigation was initiated with the objective of 
examining the effectiveness of light therapy in major depressive 
patient. Numerous treatment strategies have been utilized for 
treating depression despite the fact that light therapy is said to be a 
treatment without side effects. Light therapy is one of the most 
extensively used non-pharmaceutical treatments for treating 
depression. Light therapy is so called photo therapy employed for 
various physical illnesses. Bright light with an appropriate intensity 
and for a specified duration of time brings a remarkable decrease in 
the symptoms of depression. Light therapy is described based on the 
four basic parameters i.e. intensity, wavelength, and duration of 
daily exposure and timing of light exposure. Intensity is expressed in 
lux, on analyzing the earlier studies the intensity was used from 
minimum of less than 500 lux to maximum of 10,000 lux and most of 
the studies used 2,500 lux. And, in terms of the duration of light 
therapy was at least of half an hour to maximum of six hours. 
However, the timing of light therapy was evidenced in many studies 
indicate morning light exposure is found to be superior than to 
evening light exposure, [1-8] whereas others have found no 
difference. [9-13] There is no controlled studies substantiate that the 
evening light is superior to morning light. 
 
Some neuro chemists argue that a neuro chemical change occurs 
during light therapy. Bright light with a particular intensity inhibits 
the secretion of melatonin – a neuro chemical substance produced 
by the pineal gland. Eventually, the symptoms of sleep wake 
problems are remarkably reduced, which is also evidenced in 
depressive patient. The ease of light therapy, lack of serious side 
effects, cost effectiveness, possibility of out- patient application, not 
to mention high acceptance of an attractive non-pharmacological 
treatment demands evaluation in a controlled multi-centre trial in 
non-seasonal major depression. [14] Though light therapy lacks side 
effects it is quite uncommon and generally mild. Light therapy 
underwent patients sometimes complain eye strain, eye dryness, 
insomnia, headaches and irritability. These side effects could be 
eliminated by maintaining the distance from the light and reducing 





Major depression is a highly life threatening disease estimated to be 
the fourth major cause for loss in disability-adjusted life years,[15] 
and also it is estimated to be the first cause in developed countries in 
future years. Prevalence rate of depression between the years from 
1972 to 1992 have increased from 49.93 to 73.97 cases per 1000 
population.[16] Studies done in primary care clinics/center have 
estimated a prevalence rate of 21-40.45%.[17-20] Studies done in 
hospitals have shown that 5 to 26.7% of cases attending the 
psychiatric outpatient clinics have depression.[21-24] About 10% of 
the American population is affected by depression at any given 
moment.[25] Worldwide statistics show that 8,50,000 people died 
due to suicide per annum. [26] 
 
Depressive patients have diversified symptoms such as 
sleeplessness, loss of appetite, suicidal tendency, and social 
alienation. It is caused not by a single factor rather it is caused due to 
biological, genetic, and psychological influences combined with life 
stresses, disturbances in brain, biochemistry and irregularities in 
specific brain chemicals. Major depression, is one of the affective 
disorders and a mood disorder characterized by a sense of 
inadequacy, despondency, decreased activity, pessimism, anhedonia 
and sadness. These symptoms severely disrupt and adversely affect 
one’s life, sometimes results in attempt to suicide or suicide and also 
irritability, insomnia, lethargy, agitation and anxiety often 
accompany depression. Women are twice as likely as men to suffer 
from depression. [27] Higher rates of depression in women are 
associated with both biological and social factors. Depression occurs 
most frequently in women ages 25 to 44, and peaks during 
childbearing years. Depressive disorders are a group of conditions 
delineated and defined as a disturbance of mood that causes 
significant clinical distress or impairment in functioning [DSM-IV-
TR]. 
 
Almost 1 million people commit suicide due to depression and it is 
translated to 3000 deaths every day. [28] Depression is the major 
leading cause of disability for both males and females, the burden of 
depression in females is 50% higher than males. [29] Depression is 
more common amongst females than males. This higher rate of 
  S.priya et al. 
 
depression among females may be linked to biological, life cycle, 
hormonal, and psychosocial factors. And also researchers argue 
hormones directly affect the brain chemistry that controls emotions 
and mood. [30] 
 
The report on Global Burden of Disease estimates the prevalence of 
unipolar depressive episodes to be 1.9% for men and 3.2% for 
women, and the one-year prevalence has been estimated to be 5.8% 
for men and 9.5% for women. It is estimated that by the year 2020 if 
current trends for demographic and epidemiological transition 
continue, the burden of depression will increase to 5.7% of the total 
burden of disease and it would be the second leading cause of 
disability-adjusted life years [DALYs], second only to ischemic heart 
disease. [31] In view of the morbidity, depression as a disorder has 
always been a focus of attention of researchers in India. Many 
authors have tried to study its prevalence, nosological issues, and 
psychosocial risk factors including life events, symptomatology in 
the cultural context, co-morbidity, psycho- neurobiology, treatment 
outcome, prevention, disability and burden. Some of the studies have 
also tried to address various issues in children and elderly. A large 
population-based study from South India, which screened more than 
24,000 subjects in Chennai, reported overall prevalence of 
depression to be 15.1% after adjusting for age using the 2001 census 
data. [32] 
 
Generally major depression is treated with pharmacological 
interventions and psychiatric interventions such as administration 
of antidepressants, cognitive behavior therapy, family therapy, social 
support interventions and other therapeutic procedures. Besides 
light therapy is a non pharmacological intervention observed with 
remarkable improvement. The efficacy of light therapy is found to be 
high when administered with other treatment techniques. 
 
Light Therapy and Depression 
 
Initially, light therapy was used for treating seasonal affective 
disorder and was proved to have clinical treatment effects. [33-36] 
But, currently it is being used to treat other disorders such as non 
seasonal disorders. Light therapy is found to be effective for 
seasonal affective disorders and non seasonal disorders. [37] This 
was also substantiated in a generally short-term, placebo controlled 
trials. [3, 38-41] And also it has been found effective in treating 
depression in other age groups. [42, 39] The mechanism behind the 
effectiveness of light therapy in treating depression remains unclear. 
[43] However, many studies indicate that exposure to enough 
sunlight can be effective in treating depression. [34, 42, 39, 35-36] 
 
Effect of light therapy among hospitalized elderly depressive 
patients living in subtropical regions indicates the symptoms of 
depression reduced in experimental group compared to control 
group. [44] Similarly, the effect of bright light therapy on ante 
partum depression during pregnancy revealed a statistical 
significance. [45] Light therapy has widespread application; it has 
been applied for other conditions and also combined with other 
treatments yield notable improvement. Bright light therapy with 
combined therapy revealed significant improvement among 13 
female depressed patients with co morbid personality disorder. [46] 
 
An open trial of morning light therapy for ante-partum depression 
among 16 pregnant patients with major depression showed a 
significant improvement by 49% and no adverse effects of light 
therapy was found in pregnancy after three week. [47] 
 
Clinical effects of bright light therapy in comparison to the inactive 
placebo treatment for non-seasonal depression by meta analysis of 
twenty studies containing 49 reports revealed most of the studies 
applied bright light as adjunctive treatment to drug therapy, sleep 
deprivation, or both. Finally, the reviewers concluded that bright 
light therapy offers modest through promising anti-depressive 
efficacy, especially when administered during the first week of 
treatment, in the morning, and as an adjunctive treatment to sleep 
deprivation responders. And also they suggested hypomania is the 
adverse effects of that need to be considered. [48] 
 
A randomized controlled trial of bright light therapy on antepartum 
depression among ten pregnant women with DSM IV criteria of 
depression were randomly assigned to 5 weeks clinical trials with 
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either a 7000 lux or 500 lux placebo light box showed the result that 
throughout the randomized controlled trail, there was a small group 
advantage of active treatment and no statistical significance 
obtained whereas a clear treatment effect produced in the longer 10 
week trials in terms of active versus placebo light. [45] 
 
Efficacy of light therapy in treating the mood disorders by a 
systematic review pertaining to the randomized controlled trials on 
light therapy for mood disorders revealed the severity of symptoms 
of depression was associated with bright light treatment, and dawn 
simulation in seasonal affective disorder, and with bright light 
treatment in non-seasonal depression. Bright light as an adjunct to 
antidepressant pharmacotherapy for non-seasonal depression was 
not effective. Other than the empirical studies some of the review 
also supports the light therapy studies herein attempted. [49] 
 
A systematic review on efficacy of light therapy on non seasonal 
depression included sixty two reports identified among them 15 met 
the pre defined inclusion criteria revealed efficacy of light therapy as 
an adjuvant treatment to antidepressants. And the authors 
concluded that Overall, bright light therapy is an excellent candidate 
for inclusion into the therapeutic inventory available for the 
treatment of nonseasonal depression today, as adjuvant therapy to 
antidepressant medication. [50] 
 
Bright light or imipramine for treating inpatient suffering from non 
seasonal major depressive disorder by including 34 in-patients with 
DSM III-R criteria were included for the study revealed there was a 
significant improvement in the group received light therapy and 
imipramine. [51] 
 
This has been proved with a variety of psychological and physical 
illnesses such as seasonal depression, non-seasonal depression, 
major depression, ante-partum and post partum depression, anoxia 
nervosa and bulimia, premenstrual dysphoric disorder, attention 
deficit and hyperactivity disorder and sleep wake problems etc. 
Hence, the present piece of clinical trial will ensure the further 
researchers in carrying out noteworthy studies and clinicians to 
accomplish evidence based practices and to enhance the knowledge 
in the utilization of light therapy. Further, such a major life 
threatening disorder could be treated in a multidisciplinary 
approach whereas the study, herein conducted was an experimental 




The methodology herein employed to achieve the objectives of the 
present study was experimental in nature. To carry out the study 
approval from the institutional ethical committee was obtained. The 
study was conducted in the female psychiatric ward of Coimbatore 








During the study period a single subject was hospitalized, due to the 
availability of the sample, convenience of the researcher and based 
on the criteria of sample selection, a female participant aged 39 
years was included for the study. Her educational qualification was 
10th grade. And there was no evidence found regarding the previous 




The inclusion criteria for the subject was 
Client who met the DSM IV criteria for depression 




The exclusion criteria for the subject was 
 
Client with co-morbid psychiatric illness  
Client with visual disturbances 
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One female participant who met the inclusion criteria was 
selected for the study. Informed consent was obtained from the 




Hamilton Rating Scale for Depression [52] was administered to 
assess the level of depression in each assessment phase. The Scale is 
a 21 item self reported inventory with the scoring ranged from 0 to 
53. 
 
The Hamilton Rating Scale for Depression: The Hamilton Rating 
Scale for Depression. [52] The scale contains 21 items of which only 
17 are used to give a total score of severity. The items are concerned 
with symptoms of illness and not with traits of personality. The four 
items are excluded because they occur too infrequently. The 
questions are divided into 2 groups-Specific Symptoms and Somatic 
Symptoms. Specific symptoms measure the following aspects i.e 
depressed mood, guilt, suicide, insomnia – initial, middle, delayed, 
work and interests, retardation, agitation and anxiety. Under 
somatic symptoms the following aspects are measured. They are 
gastrointestinal, general, genital symptoms, hypochondriasis, loss of 
insight, loss of weight, diural variation, depersonalization and 
derealisation, paranoid symptoms, obsessional symptoms, 
helplessness, hopelessness and worthlessness. 
 
Scoring: It has a 3 grade, items and 5 grade items. For items with 3 
grade it is a 3 point scale-absent-0, doubtful-1, present-2. For items 
with 5 levels the last level is split into 3 grades of mild-2, moderate-3 
and severe- 4. 
 
Reliability and Validity: Validity of the scale has been compared with 
clinical “global judgment”. The inter rater reliability was 0.88 and 
therefore this sets an upper limit to validity measured in this way. 
Reliability for the total score ranges from 0.87 to 0.95. Reliability for 
individual items ranges from 0.45 to 0.78. 




Single Subject Experimental [N=1] [A-B-A] design was employed to 
evaluate the effectiveness of light therapy. To ascertain the 
consistency of depression level, three consecutive assessments were 
made with equal time interval of 30 minutes prior to the initiation of 
light therapy. Followed by these assessment phase, light therapy was 
administered for 30 minutes. Subsequent to this interventional 
phase, the level of depression was assessed to ensure the efficacy of 




Prior to initiate the light therapy, benefits of the interventional 
procedure was evidently elucidated and informed consent was 
obtained from the client’s caregivers. The client was seated 
comfortably and the bright white light with the intensity of 10000 
lux was fixed in a 30 degree angle and one feet distance from the 
client’s face. Followed by this the client was instructed to keep open 
the eyes and see the light and not to stare or close. This procedure 
was continued for 30 minutes per day for 7 consecutive days. During 
this period of intervention, administration of antidepressants, 




To identify the effectiveness of light therapy, ongoing assessment 
was performed and the collected data on each day compared before 
and after light therapy. Further, the mean comparison was made 
between the level of depression on the first day and the last day of 
intervention. Paired “t” test was employed to analyze the data with  




Table 1 indicates the Mood pattern, sleep pattern, Appetite, 
Grooming, Psychomotor activity, Suicidal ideation and Somatic 
Symptoms of the patient during the course of intervention. 
 
TABLE 1: ONGOING ASSESSMENT OF DEPRESSIVE SYMPTOMS 
 
AREA OF 
DAY 1 DAY 2 DAY 3 DAY 4 DAY 5 DAY 6 DAY 7  
ASSESSMENT         
 
        
 
Mood Depressed Depressed Depressed Depressed Normal Normal Pleasant 
 
Sleep Pattern Slept only for ½ Slept only for ½ Slept only for ½ Slept for 2 Slept for 2 Slept for an Slept for 4  
an hour an hour an hour hours hours hour hours   
 
 
Anorexia. Anorexia. Consumed One Consumed 2 Consumed 2 Consumed 2 Consumed 2   meals per meals per  
Appetite Consumed one Consumed one meal per day meals per day meals per day  
day day   meal / day with meal / day with with with with   with with   compulsion compulsion compulsion compulsion compulsion   compulsion compulsion        
 
Grooming Shabbily groomed Shabbily Shabbily Shabbily Shabbily Well Well  
groomed groomed groomed groomed groomed groomed    
 
Psychomotor Increased Slight 
     
 
Psychomotor Normal Normal Normal Normal Normal  
activity restlessness  
activity              
 
Suicidal 
Present Present Present Present Absent Absent Absent  
ideation               
 
 Head ache, Head ache, 
Head ache, Head ache,  Mild head Mild head  
Somatic palpitation, palpitation, Mild head ache, ache,  
indigestion indigestion ache,  
symptoms indigestion indigestion indigestion indigestion  
present present indigestion   present present          
 
 
TABLE 2 : Level of Depression before and after Light Therapy 
 
 
Mean S.D. Mean Mean ‘t’   % Difference      
 
Before 
23.57 8.55 44.47    
therapy       0.86 3.445*  
After     
22.71 8.11 42.85    
therapy         
  
*Significant at 0.05 level 
 
 
Table 1 depicts the mean difference in the level of depression 
between before and after light therapy. The table clearly shows the 
mean value of depression significantly reduced after light therapy.  
The t value is significant at 0.05 level. Hence, the hypothesis “There 



























FIG. 1: LEVEL OF DEPRESSION BEFORE AND AFTER LIGHT 
THERAPY. 
 
FINDINGS RELATED TO LEVEL OF DEPRESSION 
 
TABLE 3: BASELINE DATA BEFORE LIGHT THERAPY 
 
The following table comprises of data collected before the 






     
 
1 2 3    
 
      
 DAY 1 38 38 37 
 
 DAY 2 33 33 33 
 
 DAY 3 25 26 25 
 
 DAY 4 22 21 21 
 
 DAY 5 17 16 15 
 
 DAY 6 15 16 16 
 
 DAY 7 14 14 14 
 
 
The above table shows the baseline data of depression during the 
study period before administering light therapy. Three consecutive 
assessments were made with equal time interval to ascertain the 
consistency of depression level before light therapy. The data clearly 
shows the trend of depression level from the day 1 to day 7 is found 
to be consistent before light therapy. 
 
TABLE 4: BASELINE DATA AFTER LIGHT THERAPY 
 
The following table indicates the level of depression after 30 
minutes interval of light therapy 
 
DAYS BASELINE DATA 
DAY 1 37 
DAY 2 31 
DAY 3 25 
DAY 4 21 
DAY 5 16 
DAY 6 15 
DAY 7 14  
The above table reveals that the level of depression decreased after 
light therapy. From this result it can be interpreted that the light 




The present result demonstrates that the light therapy has 
significantly reduced the symptoms of depression and there was an 
association between withdrawal of light therapy and depressive 
symptoms. Similarly, morning light therapy provided antidepressant 
effect to pregnancy women [47] and light therapy significantly 
reduced antepartum depression. [45] Another study indicates the 
symptoms of depression reduced in experimental group compared 
to control group. [44] Likewise, light therapy with combined therapy 
revealed significant improvement in depression with co morbid 
personality disorder. There was a significant improvement after 
light therapy combined with imipramine. [51] Hence, the present 
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result is consistent with the previous findings of open trial of 
morning light therapy for ante-partum depression [47] bright light 
therapy on antepartum depression among ten pregnant women,[45] 
light therapy among hospitalized elderly depressive patients living 
in subtropical [44] and inpatient suffering from non seasonal major 
depressive disorder.[51] In addition to the support of these study 
findings some meta- analyses also support the present finding. 
 
Meta-analyses on efficacy of light therapy also strongly supports the 
present findings. And almost all researchers in the above cited 
studies suggests bright light therapy will be an adjunct to 
pharmacotherapy and also they recommend light therapy is an 
excellent candidate to be included into the therapeutic inventory in 
the treatment of depression and non seasonal depression. [48-50] 
 
In the present study the efficacy of light therapy was ascertained 
without the administration of any other psychiatric or allied 
treatments. Since, the effect of light therapy was stringently 
monitored in each occasion. And this result herein attained 
substantiate light therapy can be administered to treat seasonal, non 
seasonal depressions with or without antidepressants. 
 
The present study comprised only a single participant which limits 
the generalization both in number and gender. Because of single 
subject experimental design no control subject comparison was 
made. Moreover, the study was conducted in only one hospital, in 
future, researchers may extend the study setting and include more 
sample of subjects. 
 
From the present investigation we conclude that a course of light 
therapy of 10,000 lux administered for 30 minutes per day for 7 
consecutive days will have a significant impact on depressive 
symptoms of major depressive client. It is therefore recommended 
that light therapy can be used to decrease depressive symptoms in 
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